Welcome to LookChem.com Sign In|Join Free
  • or
3-bromo-5-chloro-benzenesulfonyl chloride is a sulfonyl chloride derivative with the molecular formula C6H3BrClO2S and a molecular weight of 259.51 g/mol. It features bromine and chlorine substitutions on the benzene ring, contributing to its high reactivity and versatility in organic synthesis.

1049026-36-9

Post Buying Request

1049026-36-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1049026-36-9 Usage

Uses

Used in Pharmaceutical Industry:
3-bromo-5-chloro-benzenesulfonyl chloride is used as a reagent in the synthesis of pharmaceutical compounds due to its ability to form covalent bonds with a wide range of nucleophiles. This property makes it a valuable tool in the development of various chemical intermediates for drug discovery and production.
Used in Agrochemical Industry:
In the agrochemical sector, 3-bromo-5-chloro-benzenesulfonyl chloride serves as a key reagent for the synthesis of agrochemicals. Its high reactivity allows for the creation of novel compounds with potential applications in crop protection and pest control.
Safety Considerations:
Due to the potential for hazardous reactions, 3-bromo-5-chloro-benzenesulfonyl chloride should be handled with caution. It is essential to store and use 3-bromo-5-chloro-benzenesulfonyl chloride in a controlled environment to minimize risks associated with its reactivity.

Check Digit Verification of cas no

The CAS Registry Mumber 1049026-36-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,9,0,2 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1049026-36:
(9*1)+(8*0)+(7*4)+(6*9)+(5*0)+(4*2)+(3*6)+(2*3)+(1*6)=129
129 % 10 = 9
So 1049026-36-9 is a valid CAS Registry Number.

1049026-36-9Upstream product

1049026-36-9Relevant academic research and scientific papers

ACLY INHIBITORS AND USES THEREOF

-

Paragraph 00607, (2020/06/01)

The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.

Design and synthesis of benzenesulfonamide derivatives as potent anti-influenza hemagglutinin inhibitors

Tang, Guozhi,Lin, Xianfeng,Qiu, Zongxing,Li, Wentao,Zhu, Lei,Wang, Lisha,Li, Shaohua,Li, Haodong,Lin, Wenbin,Yang, Mei,Guo, Tao,Chen, Li,Lee, Daniel,Wu, Jim Z.,Yang, Wengang

supporting information; experimental part, p. 603 - 607 (2011/10/09)

Structural optimization of salicylamide-based hemagglutinin (HA) inhibitor 1 resulted in the identification of cis-3-(5-hydroxy-1,3,3- trimethylcyclohexylmethylamino)benzenesulfonamide 28 and its derivatives as potent anti-influenza agents. The lead compo

SULFONAMIDE COMPOUNDS AND THE USE

-

Page/Page column 26, (2010/02/17)

The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.

NEW ARYLSULPHONYLGLYCINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS

-

Page/Page column 141-142, (2009/12/02)

The invention relates to substituted arylsulphonylglycine derivatives of general formula (I) wherein the groups Ra to Rf, A and Z are defined as in the specification and claims, which are suitable for preparing a pharmaceutical composition for the treatment of metabolic disorders, particularly type 1 or type 2 diabetes mellitus.

ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS

-

Page/Page column 86, (2009/04/25)

The invention relates tosubstitutedarylsulphonylaminomethylphosphonic acid derivativesof general formula (I) wherein the groups Ra to Rf, A and Z are defined as mentioned in the specification and claims, which are suitable for preparinga medicament for the treatmentof metabolic disorders, particularlytype 1 or type 2 diabetesmellitus.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1049026-36-9